Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
TESARO, Inc. (TSRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/01/2018 8-K Quarterly results
Docs: "TESARO ANNOUNCES THIRD-QUARTER 2018 OPERATING RESULTS · ZEJULA® Q3 net sales totaled $63 million compared to $39 million for Q3 2017 · Top-line results for PRIMA trial of ZEJULA monotherapy for first-line ovarian cancer patients regardless of BRCA mutation status anticipated in late 2019 · Data presented at ESMO for TSR-042 indicate robust activity in patients with MSI-high endometrial cancer; TSR-042 BLA submission planned for 2H 2019"
05/03/2018 8-K Quarterly results
Docs: "TESARO ANNOUNCES FIRST-QUARTER 2018 OPERATING RESULTS"
02/27/2018 8-K Quarterly results
Docs: "TESARO ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 OPERATING RESULTS"
11/07/2017 8-K Quarterly results
Docs: "TESARO ANNOUNCES THIRD-QUARTER 2017 OPERATING RESULTS"
08/08/2017 8-K Quarterly results
Docs: "TESARO ANNOUNCES SECOND-QUARTER 2017 OPERATING RESULTS"
05/09/2017 8-K Form 8-K - Current report
02/28/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/04/2016 8-K Quarterly results
Docs: "TESARO ANNOUNCES SECOND-QUARTER 2016 OPERATING RESULTS"
05/05/2016 8-K Form 8-K - Current report
02/25/2016 8-K Quarterly results
Docs: "TESARO ANNOUNCES FOURTH-QUARTER 2015 OPERATING RESULTS",
"TESARO, Inc. slides for February 25, 2016 conference call and webcast for the quarter and year ended December 31, 2015"
10/29/2015 8-K Quarterly results
Docs: "TESARO ANNOUNCES THIRD-QUARTER 2015 OPERATING RESULTS"
08/06/2015 8-K Quarterly results
Docs: "TESARO ANNOUNCES SECOND-QUARTER 2015 OPERATING RESULTS"
04/30/2015 8-K Quarterly results
Docs: "TESARO ANNOUNCES FIRST-QUARTER 2015 OPERATING RESULTS"
02/19/2015 8-K Quarterly results
Docs: "TESARO ANNOUNCES FOURTH-QUARTER 2014 OPERATING RESULTS",
"TESARO, Inc. slides for February 19, 2015 conference call and webcast for the quarter and year ended December 31, 2014"
11/05/2014 8-K Quarterly results
Docs: "TESARO ANNOUNCES THIRD-QUARTER 2014 OPERATING RESULTS",
"TESARO, Inc. slides for November 5, 2014 conference call and webcast for the quarter ended September 30, 2014"
07/24/2014 8-K Quarterly results
Docs: "TESARO ANNOUNCES SECOND-QUARTER 2014 OPERATING RESULTS",
"TESARO, Inc. slides for July 24, 2014 conference call and webcast for the quarter ended June 30, 2014"
04/30/2014 8-K Quarterly results
Docs: "TESARO ANNOUNCES FIRST-QUARTER 2014 OPERATING RESULTS",
"TESARO, Inc. slides for April 30, 2014 conference call and webcast for the quarter ended March 31, 2014"
02/19/2014 8-K Quarterly results
Docs: "TESARO ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2013 OPERATING RESULTS",
"TESARO, Inc. slides for February 19, 2014 conference call and webcast for the quarter and year ended December 31, 2013"
11/07/2013 8-K Form 8-K - Current report
07/25/2013 8-K Form 8-K - Current report
04/25/2013 8-K Form 8-K - Current report
02/14/2013 8-K Investor presentation, Quarterly results
Docs: "TESARO Announces Fourth Quarter and Year-end 2012 Operating Results · Niraparib to be Advanced in a Phase 3 Pivotal Trial for Ovarian Cancer · Enrollment Continues in the Global Registration Program for Rolapitant · Achieved Third Dose-level in a Phase 1/2 Clinical Trial of TSR-011 Waltham, Massachusetts — February 14, 2013",
"TESARO, Inc. slides on development status of niraparib, dated February 2013"
10/25/2012 8-K Form 8-K - Current report
07/26/2012 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy